The Infusion Blog

Blog articles are primarily written by voices of the infusion industry. The opinions of guest authors do not necessarily represent or reflect the opinions or positions of NICA. 

The following post has been provided by NICA Industry Partner, Cardinal Health.  Written by: Sonia T. Oskouei, PharmD, BCMAS, DPLA Vice President of Biosimilars, Cardinal Health   Biologics are the fastest growing class of drugs in the United States; they bring innovative, life-changing treatments to patients with cancer and chronic diseases. Due to exclusive patents, they are also very expensive and out of reach for many. When patent exclusivity end for originator biologics, that opens
Written by Jacqui Rose, CEO of Pinnacle Revenue & Bryan Johnson, CEO of WeInfuse with support from Paige Bigley, Client Success, Product & Integrations at WeInfuse. Disclaimer: This blog article is merely a resource and shall not be considered professional billing advice. Use the advice outlined herein at your own risk. Originally published on July 21, 2021, on the WeInfuse IV Insights Infusion Center Blog. The original article can be found by clicking here. The
Written by Dan McCarty, Chief Executive Officer at Infusion for Health Forgive me while I state some obvious realities about the market we’ve chosen to work in: Surviving as an independent medical provider in today’s environment is difficult. The fact of the matter is that regulations continue to change and the costs to effectively address these changes – while maintaining  high quality care for patients – continue to rise. Meanwhile, there is significant downward pressure
How Hard is it for Infusion Centers to Handle their Own Billing? I get this question a lot, and the answer is really complex. There are so many intricacies in the world of infusion billing, and the thought process might not always seem logical. We face several steps to get a claim coded, submitted, and paid in full. This blog post is intended to offer a glimpse of what challenges infusion providers face in managing
Written by Angie Baker and Stef Parks, Leaders in Patient Access and Reimbursement As many drug manufacturers continue to develop new and innovative therapies for multiple disease states, we continue to see an evolution in the system through which payers (insurance companies/PBMs) use to process and pay claims. Copay accumulators have been present in the specialty pharmacy space for oral drugs for some time, causing many challenges for chronically ill patients as they fall under
Written by Charlie Schadewald-President and CEO, Wasatch Infusion Wasatch Infusion has been serving the needs of Utah patients for over 10 years, and will soon have five locations. Our growth is attributed to great people, and I’d like to share with you some of our successes and failures in our attempt to capture and retain the best talent throughout our growth: Success – Clear titles and job descriptions In the early growth stage of business,
Tags: ,
Our very own Kaitey Morgan, Director of Quality and Standards, wrote an insightful post for The WeInfuse Blog regarding the importance of thorough clinical documentation and best practices. Read the following excerpt for a sneak peek, and then follow the link below to read the full post on the WeInfuse site. As the saying goes: if it wasn’t documented, it wasn’t done. This mantra is instilled in nurses throughout our education and training, and for good reason.

Log in with your credentials


Forgot your details?

Create Account